| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | GNWE7KJ995 |
Pharmacology
| Primary Target | |
|---|---|
| complement C1s |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 1 | D016553 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 2049079-64-1 |
| ChEMBL | CHEMBL4297832 |
| FDA SRS | GNWE7KJ995 |
| Guide to Pharmacology | 9807 |
CONTENTS